L 12 Pill - yellow round
Pill with imprint L 12 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Lannett Company, Inc.
Letrozole is used in the treatment of Breast Cancer, Adjuvant; Breast Cancer, Metastatic; Breast Cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for L 12
Letrozole
- Imprint
- L 12
- Strength
- 2.5 mg
- Color
- Yellow
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Aromatase inhibitors, Hormones/antineoplastics
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Lannett Company, Inc.
- National Drug Code (NDC)
- 00527-1712
- Inactive Ingredients
-
mannitol,
microcrystalline cellulose,
lactose monohydrate,
sodium starch glycolate type A potato,
magnesium stearate,
polyvinyl alcohol,
polyethylene glycol 3350,
titanium dioxide,
magnesium silicate,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related images for "L 12"
More about letrozole
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (367)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: aromatase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.